Clinical Trial Update: A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury [Phase 1]

View source ↗

Summary

Phase 1 trial update describing the safety study of a delivery device used to administer LCTOPC1 to participants with spinal cord injury; recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• LCTOPC1

Snippet

Sponsor: Lineage Cell Therapeutics, Inc. | Conditions: Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic | Phase 1 | Status: RECRUITING